Correlation Between Visa and Windtree Therapeutics
Can any of the company-specific risk be diversified away by investing in both Visa and Windtree Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Windtree Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Windtree Therapeutics, you can compare the effects of market volatilities on Visa and Windtree Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Windtree Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Windtree Therapeutics.
Diversification Opportunities for Visa and Windtree Therapeutics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Visa and Windtree is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Windtree Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Windtree Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Windtree Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Windtree Therapeutics has no effect on the direction of Visa i.e., Visa and Windtree Therapeutics go up and down completely randomly.
Pair Corralation between Visa and Windtree Therapeutics
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.11 times more return on investment than Windtree Therapeutics. However, Visa Class A is 9.27 times less risky than Windtree Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Windtree Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 34,806 in Visa Class A on May 4, 2025 and sell it today you would lose (871.00) from holding Visa Class A or give up 2.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.41% |
Values | Daily Returns |
Visa Class A vs. Windtree Therapeutics
Performance |
Timeline |
Visa Class A |
Windtree Therapeutics |
Visa and Windtree Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and Windtree Therapeutics
The main advantage of trading using opposite Visa and Windtree Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Windtree Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Windtree Therapeutics will offset losses from the drop in Windtree Therapeutics' long position.Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
Windtree Therapeutics vs. Dermata Therapeutics | Windtree Therapeutics vs. Kiora Pharmaceuticals | Windtree Therapeutics vs. Palisade Bio | Windtree Therapeutics vs. Entero Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |